Drugs / 18F-ASIS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03790423 | Jan → Nov 2019 | breast cancer, cervical cancer, lung cancer, malignant pancreatic neoplasm +1 | Rigshospitalet, Denmark | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-ASIS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03790423 ↗ |
| Modality | Diagnostic / imaging agent | “companion imaging diagnostic agent” NCT03790423 ↗ |